CURLF trade ideas
CURLF logn term bullishOTC stock
Already broke out
Among U.S. vertically integrated multistate operators (MSO), none is larger than Curaleaf (OTC:CURLF). On a pro forma basis (i.e., assuming its pending acquisitions close), Curaleaf will have 131 retail licenses spanning 19 states. The acquisition of Select, as well as privately held MSO Grassroots, may even give Curaleaf a shot at $1 billion in annual sales this year, according to the company's management team. Look for the November elections to play a big role in drumming up investor interest in U.S. MSOs this year.
Signs of revival in Curaleaf Holdings Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
Reversal in Curaleaf Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
$CURLF Some levels to watch for a Bounce in CuraleafLets hope that 2020 brings some relief for this sector that has been fodder for the shorts and under some controversial circumstances as analysts seem to placer downgrades at key levels on any signs of recovery.
Average analysts price target $11.00
Curaleaf Holdings announced that its has received commitments from a syndicate of lenders for the purpose of structuring a new USD $275 million financing.
The financing will be set up as a Senior Secured Term Loan Facility and carry with it a 13% per annum interest rate. The loan facility would mature 48 months from closing with interest payable quarterly in arrears. Since the loan facility does not include an equity component, it will not dilute the existing positions of Curaleaf shareholders.
Company profile
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
$CURLF Leverages 50-day MA Support after RSI Div Buy SignalCURLF
Shares of Curaleaf Holdings Inc (OTCMKTS:CURLF) continue to broadly outperform the broad scope of the pot stock market at this point. The stock is now sitting above its 50-day simple moving average as we close out November and head into the final month of the year. To further that narrative, the company just announced that it will launch its custom-designed Veterans Cannabis Project pre-roll product in Florida.
Read More at: dailytrendingstocks.com
Curaleaf Long way to run higher. Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
Trade the Bounce In Curaleaf IncRsi has bounced from historical lower trend line.
Stock kas historically traded well from hitting lower BB.
Volume is improving and there is notable Bullish divergence on the OBV indicator
COMPANY PROFILE
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.
FDA brings they Buyers back into Curaleaf Holdings.Maybe not exactly what they Bears expected to happen but Curaleaf Management have actually turned a bad situation into a positive, rather than fighting the FDA, a warm welcome has been extended a proactive measures taken to comply.
The company is in a high growth trajectory and maybe see the FDA involvement as the start of washing the bad actors out of the retail side of the industry.
AVERAGE ANALYSTS PRICE TARGET $19.30
AVERAGE ANALYSTS RECOMMENDATION BUY
P/E RATIO
SHORT INTEREST
COMPANY PROFILE
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.